Immunobiotech Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 5

Immunobiotech General Information

Description

Developer of microbiomes intended to focus on food bio and pharmaceutical bio to develop them as new materials. The company specializes in the research and development of Kimchi lactic acid bacteria, lactobacillus, yeast fungus and fermentation organism.

Contact Information

Website
www.immunobiotech.co.kr
Formerly Known As
Biogenicskorea Co. Ltd., Biogenicskorea
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 8th floor, 97 Jungdaero
  • Songpa-gu
  • Seoul
  • South Korea
+82
Primary Industry
Other Pharmaceuticals and Biotechnology
Parent Company
SD Biotechnologies
Corporate Office
  • 8th floor, 97 Jungdaero
  • Songpa-gu
  • Seoul
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunobiotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Immunobiotech‘s full profile, request access.

Request a free trial

Immunobiotech Patents

  • 12

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • Pending

  • Expiring in next 12 mo

Immunobiotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019004684-A2 Cosmetic composition for reducing skin wrinkle or moisturizing skin, comprising nano-sized kimchi lactic acid bacteria Inactive 30-Jun-2017
WO-2019004684-A3 Cosmetic composition for reducing skin wrinkle or moisturizing skin, comprising nano-sized kimchi lactic acid bacteria Inactive 30-Jun-2017
WO-2018021874-A1 Functional sanitary napkin Inactive 29-Jul-2016
US-20160074443-A1 Nano-sized kimchi lactic acid bacteria Active 29-May-2013
US-9763988-B2 Nano-sized kimchi lactic acid bacteria Active 29-May-2013 A61K35/747
To view Immunobiotech’s complete patent history, request access »

Immunobiotech Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Immunobiotech‘s full profile, request access.

Request a free trial

Immunobiotech FAQs

  • When was Immunobiotech founded?

    Immunobiotech was founded in 2013.

  • Where is Immunobiotech headquartered?

    Immunobiotech is headquartered in Seoul, South Korea.

  • What industry is Immunobiotech in?

    Immunobiotech’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Immunobiotech a private or public company?

    Immunobiotech is a Private company.

  • What is Immunobiotech’s current revenue?

    The current revenue for Immunobiotech is .

  • How much funding has Immunobiotech raised over time?

    Immunobiotech has raised $8.4M.

  • Who are Immunobiotech’s investors?

    IREM, Nexture, and WellBiotech have invested in Immunobiotech.

  • When was Immunobiotech acquired?

    Immunobiotech was acquired on 01-Jan-2023.

  • Who acquired Immunobiotech?

    Immunobiotech was acquired by SD Biotechnologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process